Drug Chatter -- Tracking biopharma stock chatter

Profile for MediciNova, Inc. (MNOV)

« Back to company index

MNOV Chatter Timeline

Stock Ticker for MNOV

Most Active Tweeters for MNOV

UserTweets
@ensankai 8
@biotech_sector 3
@paynej247 2
@GNWLive 2
@MaisaCorp 2

Recent Tweets for MNOV

danrocks4 @danrocks4
MNOV is number 41 for the largest percentage gain out of 100 stocks. $MNOV Medicinova Inc is up +15.26% in the https://t.co/FsEIL2stBg
September 25th 2017, 10:09am
ensankai @ensankai
RT @ensankai: $MNOV Is there anybody having any comment on the Conference in NYC next Tue? https://t.co/BbxE8okJE2
September 25th 2017, 1:09am
ensankai @ensankai
RT @ensankai: MN-166(ibudilast) portfolio of $MNOV 4875 MEDICINOVA,INC bids fair to get result of the trial Autumn. https://t.co/tuR9V23uiA…
September 25th 2017, 1:09am
ensankai @ensankai
RT @ensankai: US government could consider best MN-166, the PL of $MNOV 4875 MEDICINOVA,INC. https://t.co/Bg4AyzWUew
September 25th 2017, 1:09am
ensankai @ensankai
RT @ensankai: Janet, 4875 MEDICINOVA,INC $MNOV https://t.co/trlAv7tLcg has the up-and-coming PL for opioid abuse, MN-166. https://t.co/QIQL…
September 25th 2017, 1:09am
ensankai @ensankai
There isn't a possibility they'll release new announcement about MN-166 or another their Pipe Line at the conference, is there? $MNOV
September 24th 2017, 11:09am
ensankai @ensankai
$MNOV Is there anybody having any comment on the Conference in NYC next Tue? https://t.co/BbxE8okJE2
September 24th 2017, 11:09am
ensankai @ensankai
RT @bs2537: $MNOV: Medicinova: Phase 2b Data In Progressive Multiple Sclerosis Expected On October 28, Should You Buy? https://t.co/3hkmWCL…
September 24th 2017, 11:09am
ensankai @ensankai
RT @bs2537: $MNOV: Medicinova: Initiating Coverage With Buy Rating And First Price Target=$12 https://t.co/3SZluhg6BK
September 23rd 2017, 4:09am
paynej247 @paynej247
RT @odibro: $MNOV S-3 $200M mixed shelf filed
September 22nd 2017, 7:09pm
odibro @odibro
$MNOV S-3 $200M mixed shelf filed
September 22nd 2017, 5:09pm
MaisaCorp @MaisaCorp
$MNOV S-3 files for potential mixed ??shelf of up to $200 million
September 22nd 2017, 5:09pm
filingBot @filingBot
@DaveSD80 there is a new form S-3 filing for $MNOV https://t.co/aQSuHOekId What do you think?
September 22nd 2017, 5:09pm
roserosky @roserosky
PUMPER tryin to PUMP no volume stock SMH $MNOV
September 22nd 2017, 1:09pm
RagingBull @RagingBull
What's on @kylewdennis #watchlist? MediciNova for upcoming phase 2B data release $MNOV https://t.co/iijwxNdkc4 https://t.co/A6wvPHUjK5
September 22nd 2017, 9:09am
PatternSearch @PatternSearch
Price Channel Breakout (Reversal) pattern detected on 2017-09-21 for $MNOV - https://t.co/PHI1CJCx3N
September 21st 2017, 7:09pm
bs2537 @bs2537
$MNOV: Medicinova: Phase 2b Data In Progressive Multiple Sclerosis Expected On October 28, Should You Buy? https://t.co/3hkmWCLOeL
September 20th 2017, 3:09pm
MaisaCorp @MaisaCorp
$MNOV Completes Enrollment the Phase 2 Clinical Trial of MN-166 in Methamphetamine Dependence
September 19th 2017, 3:09pm
pharma_sector @pharma_sector
#Medicinova BRIEF-MediciNova completes enrollment in the phase 2 trial of MN-166 in methamp... Read more: https://t.co/pptx3RmCY9 $MNOV
September 19th 2017, 7:09am
biotech_sector @biotech_sector
#Medicinova BRIEF-MediciNova completes enrollment in the phase 2 trial of MN-166 in methamp... Read more: https://t.co/NJtJ4mCSYP $MNOV
September 19th 2017, 7:09am
paynej247 @paynej247
RT @odibro: $MNOV Announces the Completion of Enrollment in the P2 Clinical Trial of MN-166 in Methamphetamine Dependence. Final data Q1 20…
September 19th 2017, 7:09am
Onellymr @Onellymr
$MNOV MediciNova Announces the Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudil... https://t.co/HlxpbvWYPH
September 19th 2017, 6:09am
stockboardinc @stockboardinc
$MNOV MediciNova Announces the Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast... - https://t.co/9HpvMs8mkI
September 19th 2017, 6:09am
Allstocknews @Allstocknews
$MNOV MediciNova Announces the Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) i From our Stock News Alerts App
September 19th 2017, 6:09am
odibro @odibro
$MNOV Announces the Completion of Enrollment in the P2 Clinical Trial of MN-166 in Methamphetamine Dependence. Final data Q1 2018
September 19th 2017, 6:09am
GNWLive @GNWLive
MediciNova Announces the Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in $MNOV https://t.co/gzj8AGr0JX
September 19th 2017, 6:09am
biotech_sector @biotech_sector
#Medicinova MediciNova to Present at the Ladenburg Thalmann 2017 Healthcare Conference in N... Read more: https://t.co/9z9P2uMckf $MNOV
September 18th 2017, 7:09pm
biotech_sector @biotech_sector
#Medicinova MediciNova to Present at the Ladenburg Thalmann 2017 Healthcare Conference in N... Read more: https://t.co/iBfYIjNA4M $MNOV
September 18th 2017, 7:09pm
stockboardinc @stockboardinc
$MNOV MediciNova to Present at the Ladenburg Thalmann 2017 Healthcare Conference in New York... - https://t.co/RQazbadJPN
September 18th 2017, 7:09pm
Allstocknews @Allstocknews
$MNOV MediciNova to Present at the Ladenburg Thalmann 2017 Healthcare Conference in New York From our Stock News Alerts App
September 18th 2017, 7:09pm
GNWLive @GNWLive
MediciNova to Present at the Ladenburg Thalmann 2017 Healthcare Conference in New York $MNOV https://t.co/bQqVMoWDja
September 18th 2017, 7:09pm
JNapodano @JNapodano
Some thoughts on $MNOV MN-166 ahead of P2b data in October >> https://t.co/c3l8o4Mh4X ($)
September 18th 2017, 12:09pm
fda_tracker @fda_tracker
$MNOV Phase 2 trial w/est Sep completion date NCT02238626: https://t.co/VqQGjzgytx Trial Tracker: https://t.co/aR7q5oJwjn
September 11th 2017, 9:09am
biotech_sector @biotech_sector
#Medicinova SPRINT-MS/NN 102 Phase 2b Abstract Selected for Late-Breaking Presentation at t... Read more: https://t.co/VupjPMgAGj $MNOV
September 8th 2017, 11:09am
biotech_sector @biotech_sector
#Medicinova MediciNova, Inc. Announces The Abstract From The MN-166 (Ibudilast) SPRINT-MS P... Read more: https://t.co/rQHe13n5NZ $MNOV
September 8th 2017, 8:09am
biotech_sector @biotech_sector
#Medicinova MediciNova Announces the Abstract from the MN-166 (ibudilast) SPRINT-MS Phase 2... Read more: https://t.co/0XOP9va0CL $MNOV
September 8th 2017, 8:09am
filingBot @filingBot
@DaveSD80 there is a new form 8-K filing for $MNOV https://t.co/wDtpXUX4PH Share with your friends!
September 7th 2017, 5:09pm
rhani32 @rhani32
$MNOV watching this closely insiders buying,reversal trend soon
September 5th 2017, 11:09am
vitalhongkong @vitalhongkong
RT @DavidBautz: $MNOV P2b data for MN-166 in #multiplesclerosis to be presented on Oct. 28: https://t.co/SpomeJdXee
August 30th 2017, 9:08am
DavidBautz @DavidBautz
$MNOV P2b data for MN-166 in #multiplesclerosis to be presented on Oct. 28: https://t.co/SpomeJdXee
August 30th 2017, 7:08am
stockboardinc @stockboardinc
$MNOV MediciNova Announces the Abstract from the MN-166 (ibudilast) SPRINT-MS Phase 2b Study in Progressiv... - https://t.co/8ydW3OL4Xv
August 30th 2017, 6:08am
Allstocknews @Allstocknews
$MNOV MediciNova Announces the Abstract from the MN-166 (ibudilast) SPRINT-MS Phase 2b Study in Progressive M From our Stock News Alerts App
August 30th 2017, 6:08am
GNWLive @GNWLive
MediciNova Announces the Abstract from the MN-166 (ibudilast) SPRINT-MS Phase 2b Study in Progressive MS $MNOV https://t.co/QX05y4UxwJ
August 30th 2017, 6:08am
Jim5011 @Jim5011
MNOV Gapped up +0.07 $MNOV Last Price 5.40 Day High 5.50 Day Low 5.37 Change +0.13 Volume 13,351 Today 74 stoc https://t.co/JUlpbRIzW0
August 28th 2017, 3:08pm
InsiderAlertsIA @InsiderAlertsIA
$MNOV: New Insider Filing on Director YOSHIO ISHIZAKA: https://t.co/wIex0MV0wW
August 23rd 2017, 2:08pm
Allstocknews @Allstocknews
$MNOV ALERT: New Medicinova Inc SEC Filing From our Stock News Alerts App
August 23rd 2017, 1:08pm
danrocks4 @danrocks4
MNOV is number 97 for the largest percentage gain out of 100 stocks. $MNOV Medicinova Inc is up +7.68% in the https://t.co/CkiTfovC3x
August 22nd 2017, 11:08am
danrocks4 @danrocks4
MNOV is number 49 for the largest percentage gain out of 100 stocks. $MNOV Medicinova Inc is up +11.51% in the https://t.co/ZafZ3ZHKeR
August 18th 2017, 10:08am
vincentnovella1 @vincentnovella1
$MNOV an interesting play coming back from oversold condition. Could get a big run up in a hurry.
August 16th 2017, 1:08pm
EReid6714 @EReid6714
if you want to discover the best trade ideas for the day every morning, use this https://t.co/lIT9Rayduz $MNOV… https://t.co/3aMK30wYsR
August 15th 2017, 7:08pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.